Atripla and Nitrostat drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Atripla (efavirenz; emtricitabine; tenofovir disoproxil fumarate) and Nitrostat (nitroglycerin). Common drug interactions include decreased activity among females and anhedonia among males.
The phase IV clinical study analyzes what interactions people have when they take Atripla and Nitrostat. It is created by eHealthMe based on reports of 35 people who take the same drugs from the FDA, and is updated regularly.
What is Atripla?
Atripla has active ingredients of efavirenz; emtricitabine; tenofovir disoproxil fumarate. It is often used in hiv infection. eHealthMe is studying from 36,036 Atripla users. Check the latest studies of Atripla.
What is Nitrostat?
Nitrostat has active ingredients of nitroglycerin. It is often used in chest pain. eHealthMe is studying from 14,082 Nitrostat users. Check the latest studies of Nitrostat.
35 people who take Atripla and Nitrostat together, and have interactions are studied.

What are the common drug interactions of Atripla and Nitrostat, by gender? *:
female:
- Decreased activity
- Azotaemia (excess of urea or other nitrogenous compounds in the blood)
- Fanconi syndrome acquired (self developed genetic disease of kidney damage due to defective transport system)
- Insomnia (sleeplessness)
- Malaise (a feeling of general discomfort or uneasiness)
- Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
- Renal disorder (kidney disease)
- Renal failure (kidney dysfunction)
- Renal tubular disorder (disease of kidney tubules)
- Bradykinesia (decreased bodily movement. it is associated with basal ganglia diseases)
male:
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Muscular weakness (muscle weakness)
- Pain in extremity
- Ankle fracture
- Renal failure (kidney dysfunction)
- Multiple fractures
- Mobility decreased (ability to move is reduced)
- Neck pain
- Arthralgia (joint pain)
What are the common drug interactions of Atripla and Nitrostat, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Back pain
- Dysstasia (difficulty in standing)
- Flank pain (a distressing sensation experienced around the lower back and the upper abdomen)
- Muscular weakness (muscle weakness)
- Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
- Quality of life decreased
- Renal failure (kidney dysfunction)
- Renal injury (kidney injury)
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
50-59:
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Emotional distress
- Pain
- Bone density decreased
- Osteopenia (a condition where bone mineral density is lower than normal)
- Chronic kidney disease
- Depression
- Osteoporosis (bones weak and more likely to break)
- Ankle fracture
60+:
- Malaise (a feeling of general discomfort or uneasiness)
- Blood creatinine increased
- Renal disorder (kidney disease)
- Renal impairment (severely reduced kidney function)
- Renal tubular disorder (disease of kidney tubules)
- Acute hepatic failure
- Chills (felling of cold)
- Coma (state of unconsciousness lasting more than six hours)
- Decreased appetite
- Dyspnoea (difficult or laboured respiration)
What are the existing conditions these people have? *
- Asthma: 6 people, 17.14%
- Pain: 6 people, 17.14%
- Diarrhea: 5 people, 14.29%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 14.29%
- High Blood Cholesterol: 4 people, 11.43%
- High Blood Pressure: 4 people, 11.43%
- Bacterial Infection: 4 people, 11.43%
- Nausea (feeling of having an urge to vomit): 4 people, 11.43%
- Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 3 people, 8.57%
- Bipolar Disorder (mood disorder): 3 people, 8.57%
* Approximation only. Some reports may have incomplete information.
Do you take Atripla and Nitrostat?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Atripla and Nitrostat:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Atripla:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Nitrostat:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Atripla and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Nitrostat and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on efavirenz; emtricitabine; tenofovir disoproxil fumarate and nitroglycerin (the active ingredients of Atripla and Nitrostat, respectively), and Atripla and Nitrostat (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Acetylsalicylic Acid and Impaired Healing for Men aged 60+ - a second ago
- Could Ondansetron cause Paraparesis? - 4 seconds ago
- Sleep Disorder and Forced Expiratory Volume Decreased - 15 seconds ago
- Blood Uric Acid Increased and drugs of ingredients of mirtazapine - 22 seconds ago
- Leukopenia and drugs of ingredients of mepolizumab - 22 seconds ago
- Could Ribavirin cause Haematocrit? - 24 seconds ago
- Could Ibu cause Hyperphosphataemia? - 30 seconds ago
- Could Carvedilol cause Arthropathy? - 40 seconds ago
- Balance Disorder and Vision Blurred - 43 seconds ago
- Could Ipratropium Bromide cause Chills? - 43 seconds ago